SCHEMBL13048901

SCHEMBL13048901

C=C(C)C(=O)OCc1c2ccccc2cc2cc3ccccc3cc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.45
L3MBTL1 Q9Y468 2/20 0.37
HTR2A P28223 1/20 0.37
ALDH1A1 P00352 4/20 0.36
KDM4E B2RXH2 3/20 0.36
KMT2A Q03164 3/20 0.36
MEN1 O00255 2/20 0.36
HPGD P15428 2/20 0.36
CYP1A2 P05177 1/20 0.36
GLA P06280 1/20 0.36
CYP2C19 P33261 1/20 0.36
HSD17B10 Q99714 1/20 0.36
GAA P10253 1/20 0.36
POLB P06746 2/20 0.35
GPR35 Q9HC97 2/20 0.35
ELANE P08246 1/20 0.35
EDNRA P25101 1/20 0.35
MAPT P10636 1/20 0.35
TDP1 Q9NUW8 3/20 0.35
APEX1 P27695 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12903610 0.96 EPHX1 (0.39) EPHX1ALDH1A1KDM4EKMT2AMEN1
SCHEMBL216321 0.94 EPHX1 (0.49) EPHX1L3MBTL1HTR2AALDH1A1KDM4E
SCHEMBL29625710 0.94 EPHX1 (0.49) EPHX1L3MBTL1HTR2AALDH1A1KDM4E
SCHEMBL2014907 0.88 EPHX1 (0.43) EPHX1L3MBTL1HTR2AALDH1A1KDM4E
SCHEMBL16271329 0.83 TSHR (0.41) EPHX1ALDH1A1KDM4EKMT2AMEN1
SCHEMBL8065282 0.82 THRB (0.46) EPHX1L3MBTL1HTR2AALDH1A1KDM4E
SCHEMBL216103 0.82 MTNR1A (0.46) EPHX1ALDH1A1KDM4EKMT2AMEN1
SCHEMBL21137126 0.81 EPHX1 (0.38) EPHX1L3MBTL1ALDH1A1KDM4EKMT2A
Ammonia Solution, Strong SCHEMBL29224022 0.81 MTNR1A (0.45) EPHX1ALDH1A1KDM4EKMT2AMEN1
SCHEMBL5071502 0.80 KMT2A (0.42) EPHX1L3MBTL1ALDH1A1KDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8940472-B2 Coating compositions suitable for use with an overcoated photoresist U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT 2015-01-27 US disclosed
US-8940472-B2 Coating compositions suitable for use with an overcoated photoresist U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT 2015-01-27 US disclosed
US-20100297556-A1 Coating compositions suitable for use with an overcoated photoresist ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) 2010-11-25 US disclosed
US-20100297556-A1 Coating compositions suitable for use with an overcoated photoresist ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) 2010-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100297556-A1 Coating compositions suitable for use with an overcoated photoresist C5, FTO, DOHH EPHX1 410/4885L3MBTL1 3120/4885HTR2A 1406/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.